UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 129

of 'Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects'

129
TI
Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.
AU
Lou E, Turner S, Sumrall A, Reardon DA, Desjardins A, Peters KB, Sampson JH, Friedman HS, Vredenburgh JJ
SO
J Clin Oncol. 2011 Oct;29(28):e739-42. Epub 2011 Sep 6.
 
AD
Duke University Medical Center, Durham, NC, USA.
PMID